PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event
21 May 2023 (11:15 - 11:27)
Organised by: 
Slides
About the speaker
Duke University Medical Center, Durham (United States of America)
4 More presentations in this session
Doctor M. Vaduganathan (Boston, US)
Doctor M. Kosiborod (Kansas City, US)
Doctor R. Campbell (Glasgow, GB)
Professor A. Voors (Groningen, NL)
Access the full session
The Event
Heart Failure 2023
21 May 2023
11:15 CET
You may be interested in
Congress Presentation
Congress Session
